Global Animal Antibacterial Peptide Market Research Report 2023

Publisher Name :
Date: 27-Jan-2023
No. of pages: 89
Inquire Before Buying

Peptides are derived from animal source and possess antibacterial activity that comes under animal antibacterial peptides. They contain residue of amino acids generally about 15 to 45. Antibacterial peptides are the effector molecules of innate immunity. Majority of the antibacterial peptides are cationic in nature. In insects, the cecropin type of linear peptide without cysteine are found. Now, more than 900 sequences of proteins and antibacterial peptides from plants and animals are stored in database. The antibacterial peptides are broad spectrum in activity. The antibacterial peptides are amphipathic in structure and contains positive charge.

Highlights

The global Animal Antibacterial Peptide market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.

North American market for Animal Antibacterial Peptide is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

Asia-Pacific market for Animal Antibacterial Peptide is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

The key global manufacturers of Animal Antibacterial Peptide include Merial, Zoetis, Bayer HealthCare, Merck Animal Health, Elanco (Eli Lilly and Company), Biogenesis Bago, Animal Medics and Boehringer Ingelheim Vetmedica, etc. in 2022, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Animal Antibacterial Peptide, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Animal Antibacterial Peptide.

The Animal Antibacterial Peptide market size, estimations, and forecasts are provided in terms of sales volume (K MT) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Animal Antibacterial Peptide market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Animal Antibacterial Peptide manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.

By Company

- Merial

- Zoetis

- Bayer HealthCare

- Merck Animal Health

- Elanco (Eli Lilly and Company)

- Biogenesis Bago

- Animal Medics

- Boehringer Ingelheim Vetmedica

Segment by Type

- Anionic Peptides

- Cationic Peptide

Segment by Application

- Poultry

- Livestock

Consumption by Region

- North America

- - U.S.

- - Canada

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - India

- - Australia

- - Taiwan

- - Indonesia

- - Thailand

- - Malaysia

- - Philippines

- - Vietnam

- Latin America

- - Mexico

- - Brazil

- - Argentina

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - U.A.E

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Detailed analysis of Animal Antibacterial Peptide manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Sales, revenue of Animal Antibacterial Peptide in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 9: The main points and conclusions of the report.

Global Animal Antibacterial Peptide Market Research Report 2023

Table of Contents
1 Animal Antibacterial Peptide Market Overview
1.1 Product Overview and Scope of Animal Antibacterial Peptide
1.2 Animal Antibacterial Peptide Segment by Type
1.2.1 Global Animal Antibacterial Peptide Market Value Comparison by Type (2023-2029)
1.2.2 Anionic Peptides
1.2.3 Cationic Peptide
1.3 Animal Antibacterial Peptide Segment by Application
1.3.1 Global Animal Antibacterial Peptide Market Value by Application: (2023-2029)
1.3.2 Poultry
1.3.3 Livestock
1.4 Global Animal Antibacterial Peptide Market Size Estimates and Forecasts
1.4.1 Global Animal Antibacterial Peptide Revenue 2018-2029
1.4.2 Global Animal Antibacterial Peptide Sales 2018-2029
1.4.3 Global Animal Antibacterial Peptide Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Animal Antibacterial Peptide Market Competition by Manufacturers
2.1 Global Animal Antibacterial Peptide Sales Market Share by Manufacturers (2018-2023)
2.2 Global Animal Antibacterial Peptide Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Animal Antibacterial Peptide Average Price by Manufacturers (2018-2023)
2.4 Global Animal Antibacterial Peptide Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Animal Antibacterial Peptide, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Animal Antibacterial Peptide, Product Type & Application
2.7 Animal Antibacterial Peptide Market Competitive Situation and Trends
2.7.1 Animal Antibacterial Peptide Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Animal Antibacterial Peptide Players Market Share by Revenue
2.7.3 Global Animal Antibacterial Peptide Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Animal Antibacterial Peptide Retrospective Market Scenario by Region
3.1 Global Animal Antibacterial Peptide Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Animal Antibacterial Peptide Global Animal Antibacterial Peptide Sales by Region: 2018-2029
3.2.1 Global Animal Antibacterial Peptide Sales by Region: 2018-2023
3.2.2 Global Animal Antibacterial Peptide Sales by Region: 2024-2029
3.3 Global Animal Antibacterial Peptide Global Animal Antibacterial Peptide Revenue by Region: 2018-2029
3.3.1 Global Animal Antibacterial Peptide Revenue by Region: 2018-2023
3.3.2 Global Animal Antibacterial Peptide Revenue by Region: 2024-2029
3.4 North America Animal Antibacterial Peptide Market Facts & Figures by Country
3.4.1 North America Animal Antibacterial Peptide Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Animal Antibacterial Peptide Sales by Country (2018-2029)
3.4.3 North America Animal Antibacterial Peptide Revenue by Country (2018-2029)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Animal Antibacterial Peptide Market Facts & Figures by Country
3.5.1 Europe Animal Antibacterial Peptide Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Animal Antibacterial Peptide Sales by Country (2018-2029)
3.5.3 Europe Animal Antibacterial Peptide Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Animal Antibacterial Peptide Market Facts & Figures by Country
3.6.1 Asia Pacific Animal Antibacterial Peptide Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Animal Antibacterial Peptide Sales by Country (2018-2029)
3.6.3 Asia Pacific Animal Antibacterial Peptide Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Animal Antibacterial Peptide Market Facts & Figures by Country
3.7.1 Latin America Animal Antibacterial Peptide Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Animal Antibacterial Peptide Sales by Country (2018-2029)
3.7.3 Latin America Animal Antibacterial Peptide Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Animal Antibacterial Peptide Market Facts & Figures by Country
3.8.1 Middle East and Africa Animal Antibacterial Peptide Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Animal Antibacterial Peptide Sales by Country (2018-2029)
3.8.3 Middle East and Africa Animal Antibacterial Peptide Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Animal Antibacterial Peptide Sales by Type (2018-2029)
4.1.1 Global Animal Antibacterial Peptide Sales by Type (2018-2023)
4.1.2 Global Animal Antibacterial Peptide Sales by Type (2024-2029)
4.1.3 Global Animal Antibacterial Peptide Sales Market Share by Type (2018-2029)
4.2 Global Animal Antibacterial Peptide Revenue by Type (2018-2029)
4.2.1 Global Animal Antibacterial Peptide Revenue by Type (2018-2023)
4.2.2 Global Animal Antibacterial Peptide Revenue by Type (2024-2029)
4.2.3 Global Animal Antibacterial Peptide Revenue Market Share by Type (2018-2029)
4.3 Global Animal Antibacterial Peptide Price by Type (2018-2029)
5 Segment by Application
5.1 Global Animal Antibacterial Peptide Sales by Application (2018-2029)
5.1.1 Global Animal Antibacterial Peptide Sales by Application (2018-2023)
5.1.2 Global Animal Antibacterial Peptide Sales by Application (2024-2029)
5.1.3 Global Animal Antibacterial Peptide Sales Market Share by Application (2018-2029)
5.2 Global Animal Antibacterial Peptide Revenue by Application (2018-2029)
5.2.1 Global Animal Antibacterial Peptide Revenue by Application (2018-2023)
5.2.2 Global Animal Antibacterial Peptide Revenue by Application (2024-2029)
5.2.3 Global Animal Antibacterial Peptide Revenue Market Share by Application (2018-2029)
5.3 Global Animal Antibacterial Peptide Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Merial
6.1.1 Merial Corporation Information
6.1.2 Merial Description and Business Overview
6.1.3 Merial Animal Antibacterial Peptide Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Merial Animal Antibacterial Peptide Product Portfolio
6.1.5 Merial Recent Developments/Updates
6.2 Zoetis
6.2.1 Zoetis Corporation Information
6.2.2 Zoetis Description and Business Overview
6.2.3 Zoetis Animal Antibacterial Peptide Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Zoetis Animal Antibacterial Peptide Product Portfolio
6.2.5 Zoetis Recent Developments/Updates
6.3 Bayer HealthCare
6.3.1 Bayer HealthCare Corporation Information
6.3.2 Bayer HealthCare Description and Business Overview
6.3.3 Bayer HealthCare Animal Antibacterial Peptide Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Bayer HealthCare Animal Antibacterial Peptide Product Portfolio
6.3.5 Bayer HealthCare Recent Developments/Updates
6.4 Merck Animal Health
6.4.1 Merck Animal Health Corporation Information
6.4.2 Merck Animal Health Description and Business Overview
6.4.3 Merck Animal Health Animal Antibacterial Peptide Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Merck Animal Health Animal Antibacterial Peptide Product Portfolio
6.4.5 Merck Animal Health Recent Developments/Updates
6.5 Elanco (Eli Lilly and Company)
6.5.1 Elanco (Eli Lilly and Company) Corporation Information
6.5.2 Elanco (Eli Lilly and Company) Description and Business Overview
6.5.3 Elanco (Eli Lilly and Company) Animal Antibacterial Peptide Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Elanco (Eli Lilly and Company) Animal Antibacterial Peptide Product Portfolio
6.5.5 Elanco (Eli Lilly and Company) Recent Developments/Updates
6.6 Biogenesis Bago
6.6.1 Biogenesis Bago Corporation Information
6.6.2 Biogenesis Bago Description and Business Overview
6.6.3 Biogenesis Bago Animal Antibacterial Peptide Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Biogenesis Bago Animal Antibacterial Peptide Product Portfolio
6.6.5 Biogenesis Bago Recent Developments/Updates
6.7 Animal Medics
6.6.1 Animal Medics Corporation Information
6.6.2 Animal Medics Description and Business Overview
6.6.3 Animal Medics Animal Antibacterial Peptide Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Animal Medics Animal Antibacterial Peptide Product Portfolio
6.7.5 Animal Medics Recent Developments/Updates
6.8 Boehringer Ingelheim Vetmedica
6.8.1 Boehringer Ingelheim Vetmedica Corporation Information
6.8.2 Boehringer Ingelheim Vetmedica Description and Business Overview
6.8.3 Boehringer Ingelheim Vetmedica Animal Antibacterial Peptide Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Boehringer Ingelheim Vetmedica Animal Antibacterial Peptide Product Portfolio
6.8.5 Boehringer Ingelheim Vetmedica Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Animal Antibacterial Peptide Industry Chain Analysis
7.2 Animal Antibacterial Peptide Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Animal Antibacterial Peptide Production Mode & Process
7.4 Animal Antibacterial Peptide Sales and Marketing
7.4.1 Animal Antibacterial Peptide Sales Channels
7.4.2 Animal Antibacterial Peptide Distributors
7.5 Animal Antibacterial Peptide Customers
8 Animal Antibacterial Peptide Market Dynamics
8.1 Animal Antibacterial Peptide Industry Trends
8.2 Animal Antibacterial Peptide Market Drivers
8.3 Animal Antibacterial Peptide Market Challenges
8.4 Animal Antibacterial Peptide Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Animal Antibacterial Peptide Market Value Comparison by Type (2023-2029) & (US$ Million)
Table 2. Global Animal Antibacterial Peptide Market Value Comparison by Application (2023-2029) & (US$ Million)
Table 3. Global Animal Antibacterial Peptide Market Competitive Situation by Manufacturers in 2022
Table 4. Global Animal Antibacterial Peptide Sales (K MT) of Key Manufacturers (2018-2023)
Table 5. Global Animal Antibacterial Peptide Sales Market Share by Manufacturers (2018-2023)
Table 6. Global Animal Antibacterial Peptide Revenue (US$ Million) by Manufacturers (2018-2023)
Table 7. Global Animal Antibacterial Peptide Revenue Share by Manufacturers (2018-2023)
Table 8. Global Market Animal Antibacterial Peptide Average Price (USD/MT) of Key Manufacturers (2018-2023)
Table 9. Global Key Players of Animal Antibacterial Peptide, Industry Ranking, 2021 VS 2022 VS 2023
Table 10. Global Key Manufacturers of Animal Antibacterial Peptide, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Animal Antibacterial Peptide, Product Type & Application
Table 12. Global Key Manufacturers of Animal Antibacterial Peptide, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Animal Antibacterial Peptide by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Animal Antibacterial Peptide as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Animal Antibacterial Peptide Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global Animal Antibacterial Peptide Sales by Region (2018-2023) & (K MT)
Table 18. Global Animal Antibacterial Peptide Sales Market Share by Region (2018-2023)
Table 19. Global Animal Antibacterial Peptide Sales by Region (2024-2029) & (K MT)
Table 20. Global Animal Antibacterial Peptide Sales Market Share by Region (2024-2029)
Table 21. Global Animal Antibacterial Peptide Revenue by Region (2018-2023) & (US$ Million)
Table 22. Global Animal Antibacterial Peptide Revenue Market Share by Region (2018-2023)
Table 23. Global Animal Antibacterial Peptide Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global Animal Antibacterial Peptide Revenue Market Share by Region (2024-2029)
Table 25. North America Animal Antibacterial Peptide Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America Animal Antibacterial Peptide Sales by Country (2018-2023) & (K MT)
Table 27. North America Animal Antibacterial Peptide Sales by Country (2024-2029) & (K MT)
Table 28. North America Animal Antibacterial Peptide Revenue by Country (2018-2023) & (US$ Million)
Table 29. North America Animal Antibacterial Peptide Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe Animal Antibacterial Peptide Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe Animal Antibacterial Peptide Sales by Country (2018-2023) & (K MT)
Table 32. Europe Animal Antibacterial Peptide Sales by Country (2024-2029) & (K MT)
Table 33. Europe Animal Antibacterial Peptide Revenue by Country (2018-2023) & (US$ Million)
Table 34. Europe Animal Antibacterial Peptide Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific Animal Antibacterial Peptide Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific Animal Antibacterial Peptide Sales by Region (2018-2023) & (K MT)
Table 37. Asia Pacific Animal Antibacterial Peptide Sales by Region (2024-2029) & (K MT)
Table 38. Asia Pacific Animal Antibacterial Peptide Revenue by Region (2018-2023) & (US$ Million)
Table 39. Asia Pacific Animal Antibacterial Peptide Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America Animal Antibacterial Peptide Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America Animal Antibacterial Peptide Sales by Country (2018-2023) & (K MT)
Table 42. Latin America Animal Antibacterial Peptide Sales by Country (2024-2029) & (K MT)
Table 43. Latin America Animal Antibacterial Peptide Revenue by Country (2018-2023) & (US$ Million)
Table 44. Latin America Animal Antibacterial Peptide Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Animal Antibacterial Peptide Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa Animal Antibacterial Peptide Sales by Country (2018-2023) & (K MT)
Table 47. Middle East & Africa Animal Antibacterial Peptide Sales by Country (2024-2029) & (K MT)
Table 48. Middle East & Africa Animal Antibacterial Peptide Revenue by Country (2018-2023) & (US$ Million)
Table 49. Middle East & Africa Animal Antibacterial Peptide Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global Animal Antibacterial Peptide Sales (K MT) by Type (2018-2023)
Table 51. Global Animal Antibacterial Peptide Sales (K MT) by Type (2024-2029)
Table 52. Global Animal Antibacterial Peptide Sales Market Share by Type (2018-2023)
Table 53. Global Animal Antibacterial Peptide Sales Market Share by Type (2024-2029)
Table 54. Global Animal Antibacterial Peptide Revenue (US$ Million) by Type (2018-2023)
Table 55. Global Animal Antibacterial Peptide Revenue (US$ Million) by Type (2024-2029)
Table 56. Global Animal Antibacterial Peptide Revenue Market Share by Type (2018-2023)
Table 57. Global Animal Antibacterial Peptide Revenue Market Share by Type (2024-2029)
Table 58. Global Animal Antibacterial Peptide Price (USD/MT) by Type (2018-2023)
Table 59. Global Animal Antibacterial Peptide Price (USD/MT) by Type (2024-2029)
Table 60. Global Animal Antibacterial Peptide Sales (K MT) by Application (2018-2023)
Table 61. Global Animal Antibacterial Peptide Sales (K MT) by Application (2024-2029)
Table 62. Global Animal Antibacterial Peptide Sales Market Share by Application (2018-2023)
Table 63. Global Animal Antibacterial Peptide Sales Market Share by Application (2024-2029)
Table 64. Global Animal Antibacterial Peptide Revenue (US$ Million) by Application (2018-2023)
Table 65. Global Animal Antibacterial Peptide Revenue (US$ Million) by Application (2024-2029)
Table 66. Global Animal Antibacterial Peptide Revenue Market Share by Application (2018-2023)
Table 67. Global Animal Antibacterial Peptide Revenue Market Share by Application (2024-2029)
Table 68. Global Animal Antibacterial Peptide Price (USD/MT) by Application (2018-2023)
Table 69. Global Animal Antibacterial Peptide Price (USD/MT) by Application (2024-2029)
Table 70. Merial Corporation Information
Table 71. Merial Description and Business Overview
Table 72. Merial Animal Antibacterial Peptide Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 73. Merial Animal Antibacterial Peptide Product
Table 74. Merial Recent Developments/Updates
Table 75. Zoetis Corporation Information
Table 76. Zoetis Description and Business Overview
Table 77. Zoetis Animal Antibacterial Peptide Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 78. Zoetis Animal Antibacterial Peptide Product
Table 79. Zoetis Recent Developments/Updates
Table 80. Bayer HealthCare Corporation Information
Table 81. Bayer HealthCare Description and Business Overview
Table 82. Bayer HealthCare Animal Antibacterial Peptide Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 83. Bayer HealthCare Animal Antibacterial Peptide Product
Table 84. Bayer HealthCare Recent Developments/Updates
Table 85. Merck Animal Health Corporation Information
Table 86. Merck Animal Health Description and Business Overview
Table 87. Merck Animal Health Animal Antibacterial Peptide Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 88. Merck Animal Health Animal Antibacterial Peptide Product
Table 89. Merck Animal Health Recent Developments/Updates
Table 90. Elanco (Eli Lilly and Company) Corporation Information
Table 91. Elanco (Eli Lilly and Company) Description and Business Overview
Table 92. Elanco (Eli Lilly and Company) Animal Antibacterial Peptide Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 93. Elanco (Eli Lilly and Company) Animal Antibacterial Peptide Product
Table 94. Elanco (Eli Lilly and Company) Recent Developments/Updates
Table 95. Biogenesis Bago Corporation Information
Table 96. Biogenesis Bago Description and Business Overview
Table 97. Biogenesis Bago Animal Antibacterial Peptide Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 98. Biogenesis Bago Animal Antibacterial Peptide Product
Table 99. Biogenesis Bago Recent Developments/Updates
Table 100. Animal Medics Corporation Information
Table 101. Animal Medics Description and Business Overview
Table 102. Animal Medics Animal Antibacterial Peptide Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 103. Animal Medics Animal Antibacterial Peptide Product
Table 104. Animal Medics Recent Developments/Updates
Table 105. Boehringer Ingelheim Vetmedica Corporation Information
Table 106. Boehringer Ingelheim Vetmedica Description and Business Overview
Table 107. Boehringer Ingelheim Vetmedica Animal Antibacterial Peptide Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 108. Boehringer Ingelheim Vetmedica Animal Antibacterial Peptide Product
Table 109. Boehringer Ingelheim Vetmedica Recent Developments/Updates
Table 110. Key Raw Materials Lists
Table 111. Raw Materials Key Suppliers Lists
Table 112. Animal Antibacterial Peptide Distributors List
Table 113. Animal Antibacterial Peptide Customers List
Table 114. Animal Antibacterial Peptide Market Trends
Table 115. Animal Antibacterial Peptide Market Drivers
Table 116. Animal Antibacterial Peptide Market Challenges
Table 117. Animal Antibacterial Peptide Market Restraints
Table 118. Research Programs/Design for This Report
Table 119. Key Data Information from Secondary Sources
Table 120. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Animal Antibacterial Peptide
Figure 2. Global Animal Antibacterial Peptide Market Value Comparison by Type (2023-2029) & (US$ Million)
Figure 3. Global Animal Antibacterial Peptide Market Share by Type in 2022 & 2029
Figure 4. Anionic Peptides Product Picture
Figure 5. Cationic Peptide Product Picture
Figure 6. Global Animal Antibacterial Peptide Market Value Comparison by Application (2023-2029) & (US$ Million)
Figure 7. Global Animal Antibacterial Peptide Market Share by Application in 2022 & 2029
Figure 8. Poultry
Figure 9. Livestock
Figure 10. Global Animal Antibacterial Peptide Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 11. Global Animal Antibacterial Peptide Market Size (2018-2029) & (US$ Million)
Figure 12. Global Animal Antibacterial Peptide Sales (2018-2029) & (K MT)
Figure 13. Global Animal Antibacterial Peptide Average Price (USD/MT) & (2018-2029)
Figure 14. Animal Antibacterial Peptide Report Years Considered
Figure 15. Animal Antibacterial Peptide Sales Share by Manufacturers in 2022
Figure 16. Global Animal Antibacterial Peptide Revenue Share by Manufacturers in 2022
Figure 17. The Global 5 and 10 Largest Animal Antibacterial Peptide Players: Market Share by Revenue in 2022
Figure 18. Animal Antibacterial Peptide Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 19. Global Animal Antibacterial Peptide Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 20. North America Animal Antibacterial Peptide Sales Market Share by Country (2018-2029)
Figure 21. North America Animal Antibacterial Peptide Revenue Market Share by Country (2018-2029)
Figure 22. U.S. Animal Antibacterial Peptide Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 23. Canada Animal Antibacterial Peptide Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 24. Europe Animal Antibacterial Peptide Sales Market Share by Country (2018-2029)
Figure 25. Europe Animal Antibacterial Peptide Revenue Market Share by Country (2018-2029)
Figure 26. Germany Animal Antibacterial Peptide Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 27. France Animal Antibacterial Peptide Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 28. U.K. Animal Antibacterial Peptide Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 29. Italy Animal Antibacterial Peptide Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 30. Russia Animal Antibacterial Peptide Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. Asia Pacific Animal Antibacterial Peptide Sales Market Share by Region (2018-2029)
Figure 32. Asia Pacific Animal Antibacterial Peptide Revenue Market Share by Region (2018-2029)
Figure 33. China Animal Antibacterial Peptide Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 34. Japan Animal Antibacterial Peptide Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 35. South Korea Animal Antibacterial Peptide Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 36. India Animal Antibacterial Peptide Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 37. Australia Animal Antibacterial Peptide Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 38. Taiwan Animal Antibacterial Peptide Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. Indonesia Animal Antibacterial Peptide Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. Thailand Animal Antibacterial Peptide Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. Malaysia Animal Antibacterial Peptide Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. Philippines Animal Antibacterial Peptide Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 43. Latin America Animal Antibacterial Peptide Sales Market Share by Country (2018-2029)
Figure 44. Latin America Animal Antibacterial Peptide Revenue Market Share by Country (2018-2029)
Figure 45. Mexico Animal Antibacterial Peptide Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 46. Brazil Animal Antibacterial Peptide Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 47. Argentina Animal Antibacterial Peptide Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 48. Middle East & Africa Animal Antibacterial Peptide Sales Market Share by Country (2018-2029)
Figure 49. Middle East & Africa Animal Antibacterial Peptide Revenue Market Share by Country (2018-2029)
Figure 50. Turkey Animal Antibacterial Peptide Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 51. Saudi Arabia Animal Antibacterial Peptide Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 52. U.A.E Animal Antibacterial Peptide Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 53. Global Sales Market Share of Animal Antibacterial Peptide by Type (2018-2029)
Figure 54. Global Revenue Market Share of Animal Antibacterial Peptide by Type (2018-2029)
Figure 55. Global Animal Antibacterial Peptide Price (USD/MT) by Type (2018-2029)
Figure 56. Global Sales Market Share of Animal Antibacterial Peptide by Application (2018-2029)
Figure 57. Global Revenue Market Share of Animal Antibacterial Peptide by Application (2018-2029)
Figure 58. Global Animal Antibacterial Peptide Price (USD/MT) by Application (2018-2029)
Figure 59. Animal Antibacterial Peptide Value Chain
Figure 60. Animal Antibacterial Peptide Production Process
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Distributors Profiles
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
  • Global Analytical Standards Market Insights: Impact of COVID-19 and Future Expectations to 2028
    Published: 16-Mar-2023        Price: US 3260 Onwards        Pages: 108
    The Analytical Standards market revenue was 2055.18 Million USD in 2022, and will reach 3275.31 Million USD in 2028, with a CAGR of 8.08% during 2022-2028. This report elaborates the market size, market characteristics, and market growth of the Analytical Standards industry, and breaks down according to the type, application, and consumption area of Analytical Standards. The report also introduces players in the industry from the perspective of the industry chain and marketing cha......
  • Global Human Serum Albumin Market Insights: Impact of COVID-19 and Future Expectations to 2028
    Published: 16-Mar-2023        Price: US 3260 Onwards        Pages: 105
    The Human Serum Albumin market revenue was XX Million USD in 2022, and will reach XX Million USD in 2028, with a CAGR of XX% during 2022-2028. This report elaborates the market size, market characteristics, and market growth of the Human Serum Albumin industry, and breaks down according to the type, application, and consumption area of Human Serum Albumin. The report also introduces players in the industry from the perspective of the industry chain and marketing chain and describe......
  • Global Pharmaceutical Market Insights: Impact of COVID-19 and Future Expectations to 2028
    Published: 16-Mar-2023        Price: US 3260 Onwards        Pages: 107
    The Pharmaceutical market revenue was XX Million USD in 2022, and will reach XX Million USD in 2028, with a CAGR of XX% during 2022-2028. This report elaborates the market size, market characteristics, and market growth of the Pharmaceutical industry, and breaks down according to the type, application, and consumption area of Pharmaceutical. The report also introduces players in the industry from the perspective of the industry chain and marketing chain and describes the leading c......
  • Global Human Albumin Market Insights: Impact of COVID-19 and Future Expectations to 2028
    Published: 16-Mar-2023        Price: US 3260 Onwards        Pages: 129
    The Human Albumin market revenue was XX Million USD in 2022, and will reach XX Million USD in 2028, with a CAGR of XX% during 2022-2028. This report elaborates the market size, market characteristics, and market growth of the Human Albumin industry, and breaks down according to the type, application, and consumption area of Human Albumin. The report also introduces players in the industry from the perspective of the industry chain and marketing chain and describes the leading comp......
  • Global Softgel Capsules Market Insights: Impact of COVID-19 and Future Expectations to 2028
    Published: 16-Mar-2023        Price: US 3260 Onwards        Pages: 103
    The Softgel Capsules market revenue was 9672.28 Million USD in 2022, and will reach 15017.42 Million USD in 2028, with a CAGR of 7.61% during 2022-2028. This report elaborates the market size, market characteristics, and market growth of the Softgel Capsules industry, and breaks down according to the type, application, and consumption area of Softgel Capsules. The report also introduces players in the industry from the perspective of the industry chain and marketing chain and desc......
  • Global Soft Gelatin Capsules Market Insights: Impact of COVID-19 and Future Expectations to 2028
    Published: 16-Mar-2023        Price: US 3260 Onwards        Pages: 120
    Soft gelatin capsules, also known as soft gels, are still the leading product format in dietary supplements. Soft gelatin capsules is ideal for both the dietary supplement and pharmaceutical markets The Soft Gelatin Capsules market revenue was 4377.06 Million USD in 2022, and will reach 6272.58 Million USD in 2028, with a CAGR of 6.18% during 2022-2028. This report elaborates the market size, market characteristics, and market growth of the Soft Gelatin Capsules industry, a......
  • Global Pharma & Cosmetics Market Insights: Impact of COVID-19 and Future Expectations to 2028
    Published: 16-Mar-2023        Price: US 3260 Onwards        Pages: 101
    The Pharma & Cosmetics market revenue was 1863641.54 Million USD in 2022, and will reach 2263346.26 Million USD in 2028, with a CAGR of 3.29% during 2022-2028. This report elaborates the market size, market characteristics, and market growth of the Pharma & Cosmetics industry, and breaks down according to the type, application, and consumption area of Pharma & Cosmetics. The report also introduces players in the industry from the perspective of the industry chain and marketing cha......
  • Global Oncology (Anti-cancer Drugs) Market Research Report 2023
    Published: 16-Mar-2023        Price: US 2900 Onwards        Pages: 91
    Highlights The global Oncology (Anti-cancer Drugs) market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes. North American market for Oncology (Anti-cancer Drugs) is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 202......
  • Global Pigskin Gelatin Market Research Report 2023
    Published: 16-Mar-2023        Price: US 2900 Onwards        Pages: 113
    Gelatin is a protein obtained by boiling skin, tendons, ligaments, and/or bones with water. It is usually obtained from cows or pigs. Skin gelatin is made of fresh animal skin. Highlights The global Pigskin Gelatin market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes. The rese......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs